FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
Find answers to all your questions on live LAURUSLABS message board: Is LAURUSLABS buy or sell? Should I buy LAURUSLABS shares? Why are LAURUSLABS shares falling? Should I invest in LAURUSLABS stock?

forum

LAURUSLABS Share Price Discussion

Laurus Labs Ltd.
NSE: LAURUSLABS | BSE: 540222 | ISIN: INE947Q01010 | Sector: Pharmaceuticals and health care
Like
Reply (1)
NSE:LAURUSLABS price when posted: 597
1 Replies

LAURUSLABS - 1013341
OUR BTST #LAURASLABS FROM 595 TO 615 NOW... BOOK IT SAFE 🔥🔥🔥🔥
Recent posts in LAURUSLABS
P
Reputation: -3,489 • Yesterday 5:48 AM

Type
Buy
Instrument
LAURUSLABS
Entry Price
₹1,070
Price@Trade
₹1,066.15
Target Price
₹1,140
Stop Price
₹1,000
Valid Till
Aug 11, 2020 3:20 AM  Aug 20, 2020 3:20 AM
Margin
₹428,000 approx for 400 Qty
Status
Active
Like
Reply (2)

Type
Sell
Instrument
LAURUSLABS
Entry Price
₹1,101
Price@Trade
₹1,101
Target Price
₹1,008.05
Stop Price
₹1,146.2
Valid Till
Aug 11, 2020 3:20 AM
Margin
₹99,090 approx for 90 Qty
Status
Exited
Exit Price
₹1,052.6
Net P&L
+₹4,356 (+4.4%)
Like
Reply (1)
N
Reputation: 4,833 • Aug 7 7:23 AM
Buy Laurus Labs; target of Rs 1215: Motilal Oswal
Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 1215 in its research report dated August 01, 2020.
Moneycontrol
Like
Reply
A
Reputation: -47,926 • Aug 5 4:07 AM

Type
Sell
Instrument
LAURUSLABS
Entry Price
₹1,031
Price@Trade
₹1,031.3
Target Price
₹1,000
Stop Price
₹1,050
Valid Till
Aug 5, 2020 3:20 AM
Margin
₹1,031 approx for 1 Qty
Status
Stoploss Hit
Exit Price
₹1,050
Net P&L
-₹19 (-1.84%)
Like
Reply (2)

Type
Sell
Instrument
LAURUSLABS
Entry Price
₹977.3
Price@Trade
₹977.3
Target Price
₹889.85
Stop Price
₹1,016
Valid Till
Aug 4, 2020 3:20 AM
Margin
₹99,684.6 approx for 102 Qty
Status
Stoploss Hit
Exit Price
₹1,016
Net P&L
-₹3,947.4 (-3.96%)
Like
Reply (1)
N
Reputation: 4,833 • Aug 4 4:36 AM
13 Covid-negative businesses double profit in Q1, Street rewarding them
April-June quarter earnings show several businesses from across sectors such as FMCG, agriculture, pharmaceutical, IT and e-commerce remained unscathed by the business disruption.
The Economic Times
Like
Reply